USPTO serial 77832375
SERACARE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2013
- Examiner
- JUN, WON KYUNG WENDY
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with SERACARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LGC CLINICAL DIAGNOSTICS, INC.
MILFORD, MA
Milford, MA
Milford, MA
Milford, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mainak H. Mehta
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic chemicals, reagents or preparations for scientific, research or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for clinical, medical laboratory or manufacturing use in chemical, pharmaceutical and biotechnology industries; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry, microbiology; Reagents and tools, namely, animal serums, bovine serum albumin, and human blood products, namely, plasma, serum, cells, and human serum albumin, and chromogenic substrates, all for research purposes or manufacturing use in chemical, pharmaceutical and biotechnology industries; Chemical reagents other than for medical or veterinary purposes; Chemical preparations for scientific purposes; Chemical ingredients for use as exipients or diluents in the manufacture of pharmaceuticals; Chemical reagents for reference control, namely, genetic testing controls and controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical solutions in the nature of quality control standard solutions for testing human serum, infectious disease antibodies and antigens, human genetics, and viral nucleic acids, all for industrial use and not for medical purposes; Chemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical control serum for scientific or research use in the nature of quality controls for infectious disease and genetic testing; Biochemical standard serum for scientific or research use; Quality control standard solutions and quality control materials for testing and calibrating medical apparatus and reagents for scientific and research purposes and for clinical or medical laboratory use; Standard serum, control serum, biochemical standard serum, biochemical control serum for scientific and research purposes and for clinical or medical laboratory use | ACTIVE | Sep 26, 2001 |
| 005 | Diagnostic reagents for medical and veterinary use; Clinical medical reagents; Diagnostic chemicals, reagents or preparations for medical and veterinary use; Chemical reagents for medical and veterinary use; Chemical reagents for pharmaceutical purposes and use in the pharmaceutical industry, namely, chemical reagents for use as diluents and excipients; Testing reagents for medical or clinical use; Genetic testing controls for the testing of human serum, infectious disease antibodies and antigens, and viral nucleic acids, namely, medical diagnostic reagents and assays; Chemical reference materials, namely, quality controls and panels in the nature of human compounds for medical or veterinary use; Chemical reference specimens, namely, serological, viral, genetic and nucleic acid reference specimens in the nature of human serum, infectious disease antibodies and antigens for medical or veterinary use | ACTIVE | Sep 26, 2001 |
| 042 | Custom design and development of chemical reagents and biochemical assays; Providing reagent sample testing for others in the fields of, science and research related thereto; Research support services in the nature of assay development and validation, product development, and report generation, all in the fields of virology, immunological, biological and biochemical research | ACTIVE | Sep 26, 2001 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LGC CLINICAL DIAGNOSTICS, INC.
- Other trademarks owned by SERACARE LIFE SCIENCES, INC.
- Other trademarks owned by SERACARE LIFE SCIENCES, INC.
- Other trademarks owned by SERACARE LIFE SCIENCES, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SERACARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 21, 2024 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 21, 2024 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 21, 2024 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 21, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 26, 2023 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 17, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 5, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 10, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 10, 2020 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 10, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 12, 2020 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 17, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 17, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 13, 2013 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 12, 2013 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 11, 2013 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 6, 2013 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 24, 2013 | IUAF | USE AMENDMENT FILED | — |
| Oct 24, 2013 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 2, 2013 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 1, 2013 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 25, 2013 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 25, 2013 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 31, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 30, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 25, 2012 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 25, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 17, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 16, 2012 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 16, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 25, 2012 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 25, 2012 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 25, 2011 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 30, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 30, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 26, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 20, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 18, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 18, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 23, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2011 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 28, 2011 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 17, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 17, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 3, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2011 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Jan 31, 2011 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jan 31, 2011 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jan 31, 2011 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Oct 13, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 29, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 29, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 29, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 9, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2010 | ALIE | ASSIGNED TO LIE | — |
| Jun 21, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 26, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Sep 25, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2009 | NWAP | NEW APPLICATION ENTERED | — |